Abingdon Health Plc (AIM:ABDX)
London · Delayed Price · Currency is GBP · Price in GBX 11.00
-0.75 (-6.38%)
Jun 17, 2026, 4:19 PM GMT
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 50.92 million as of June 17, 2026. Its market cap has increased by 93.51% in one year.
Market Cap
50.92M
Enterprise Value
48.16M
Revenue
9.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.00
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 50.92M, a decrease of -49.56%. That is a compound annual growth rate of -11.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 49.84M | 79.69% |
| Dec 31, 2025 | 27.74M | -7.08% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.03B |
| GSK plc | 77.84B |
| Haleon | 29.53B |
| Smith & Nephew | 9.60B |
| Creo Medical Group | 61.76M |
| AOTI, Inc. | 61.16M |
| Kooth | 58.94M |
| Poolbeg Pharma | 55.56M |